Ultrasound Guided Rectus Sheath Block Versus Intrathecal Morphine for Postoperative Analgesia in Patients Undergoing Open Total Abdominal Hysterectomy
- Conditions
- UltrasoundPostoperative AnalgesiaRectus Sheath BlockIntrathecal MorphineTotal Abdominal Hysterectomy
- Interventions
- Drug: Rectus sheath block
- Registration Number
- NCT06837506
- Lead Sponsor
- Ain Shams University
- Brief Summary
This study aims to compare the effectiveness and safety of ultrasound-guided rectus sheath block versus intrathecal morphine for postoperative analgesia in patients undergoing open total abdominal hysterectomy.
- Detailed Description
Effective postoperative analgesia is crucial for enhancing recovery and patient satisfaction following major surgical procedures, such as total abdominal hysterectomy (TAH).
Rectus sheath block (RSB), an ultrasound-guided regional anesthesia technique, involves the injection of local anesthetic into the rectus sheath, providing analgesia to the anterior abdominal wall. RSB is used to block the sensory nerves of the anterior abdominal wall and thereby contributing to pain relief after lower abdominal surgeries.
Intrathecal morphine (ITM) provides a highly effective method of analgesia by delivering the medication directly into the cerebrospinal fluid (CSF).
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Female
- Target Recruitment
- 80
- Age: 18 - 65 years old.
- American Society of Anesthesiologists (ASA) physical status (I -II).
- Patients undergoing open total abdominal hysterectomy.
- Hepatic, renal, or cardiac disease.
- Any known allergy to local anesthetic.
- Physical or mental conditions which may vague measuring postoperative pain following surgery.
- History of chronic use of analgesic as nonsteroidal anti-inflammatory drugs (NSAIDs) or central nervous system (CNS) depressants as antiepileptic, and bleeding disorders.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Rectus sheath block group Rectus sheath block Patients will receive rectus sheath block (20 ml bilaterally, bupivacaine 0.25%) after induction of general anesthesia. Intrathecal morphine group Intrathecal morphine Patients will receive 150 µg intrathecal morphine after induction of general anesthesia.
- Primary Outcome Measures
Name Time Method Total morphine consumption 24 hours postoperatively Morphine will be administered if the visual analog scale (VAS) score is ≥ 4.
- Secondary Outcome Measures
Name Time Method Time to the first request for the rescue analgesia 24 hours postoperatively Time to the first request for the rescue analgesia (time from the end of surgery till first dose of morphine administrated)
Degree of pain 24 hours postoperatively Each patient will be instructed about postoperative pain assessment with the Visual Analogue Scale (VAS). VAS (0 represents "no pain" while 10 represents "the worst pain imaginable"). VAS will be assessed after surgery over 24 hour using VAS scale at (post-anesthesia care unit, 2, 4, 6, 12, 18, and 24 h).
Degree of patient satisfaction 24 hours postoperatively The degree of patient satisfaction will be assessed on a 5-point Likert scale patient satisfaction (1, extremely dissatisfied; 2, unsatisfied; 3, neutral; 4, satisfied; 5, extremely satisfied).
Time of hospital discharge 28 days postoperatively Time of hospital discharge will be recorded from admission till the discharge from hospital.
Degree of sedation Intraoperatively Sedation will be assessed using Modified Observer's Assessment of Alertness/Sedation Scale (MOAA/S): (5 Alert: Responds readily to name spoken in normal tone, 4: Lethargic response to name spoken in normal tone, 3: Responds only after name is called loudly and/or repeatedly, 2: Responds only after mild prodding or shaking ,1: Responds only after painful trapezius squeeze,0: Does not respond to painful trapezius squeeze).
Incidence of adverse events 24 hours postoperatively Incidence of adverse events such as hematoma, nerve damage or neuropathy, bradycardia, hypotension, nausea, vomiting, pruritis, or any other complication will be recorded.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Ain Shams University
🇪🇬Cairo, Egypt
Ain Shams University🇪🇬Cairo, EgyptSarah A Afifi, MDContact0501035864Sarah606060@gmail.comSondos Afifi, MDPrincipal InvestigatorAhmed M Eldemerdash, MDPrincipal Investigator